# Impact of US government funding freezes on the HIV response: findings from a rapid survey in 32 countries

## TL;DR

A survey of 76 clinics in 32 countries found that nearly half experienced disruptions in HIV services after US funding freezes in early 2025.

## Contribution

This study provides the first rapid assessment of how US funding freezes impacted HIV service delivery across multiple global regions.

## Key findings

- 47% of responding clinics reported disruptions in HIV-related services since January 2025.
- 28% of sites experienced medication availability disruptions, and 34% faced laboratory service disruptions.
- Only 14% of sites with service disruptions reported full resolution by mid-2025.

## Abstract

After the freezing of US foreign assistance in January 2025, the International Epidemiology Databases to Evaluate AIDS (IeDEA) conducted a rapid survey among clinics and programs actively participating in the research consortium to assess the status of HIV-related service delivery in mid-2025.

In June–July 2025, an online survey was distributed to 103 IeDEA-participating clinics/programs in 41 countries in sub-Saharan Africa, Latin America and the Caribbean, and Asia-Pacific. Survey domains included US funding-related disruptions in service delivery, medication availability, laboratory services, clinic operations, and attendant mitigation strategies. Responses were received from 76/103 (74%) clinics/programs in 32/41 (78%) countries. Descriptive statistics were used to characterize disruptions in HIV-related care and mitigation measures.

Almost half of responding sites reported disruptions in HIV-related services (47%) since January 2025, along with disruptions in medication availability (28%), laboratory services (34%), and non-research clinic operations (47%). Among those reporting disruptions in HIV-related services, only 14% reported that all disruptions were fully resolved at the time of the survey.

Given anticipated reductions in global HIV funding, government- and community-led monitoring of HIV prevention and treatment services and care outcomes are critical for informing national responses and averting reversal of progress in ending the epidemic.